Untangling the FDA approval of Aducanumab (Aduhelm) (with Dr. Alireza Atri)

06/17/21 • 35 min

It’s been nearly two decades since there has been an approved drug for the treatment of Alzheimer’s disease. In an exciting development, Biogen’s drug aducanumab (Aduhelm) received conditional approval from the US Food and Drug Administration. Dr. Alireza Atri, director at Banner Sun Health Research Institute and leader in clinical research for the past 20 years, joins the conversation to help us untangle the renewed hope in the field and the complexities surrounding this decision. Dr. Atri acknowledges that this is an important step forward in our fight to end Alzheimer’s before losing another generation, but it’s one step in a complex process ahead. Hear him discuss what steps care partners and those with the disease should take with their physician, and just how soon this treatment may be available to qualified candidates.

Disclosures

Dr. Atri disclosed relevant relationships with Biogen.

Disclosures

Dr. Atri disclosed relevant relationships with Biogen.

Previous Episode

Season 1 Revisited (with Amber Ayers)

We look back and revisit some of our favorite moments from Season 1, as well as dive a little deeper and untangle our hosts and editor/producer, Amber Ayers. The team shares what led them to connect to the dementia community and just how the idea for this podcast came to be. Don’t miss their “light bulb moments” from the first 9 episodes and which ones you should go back and re-listen to. Listeners are also in for a treat when Heather & Janice give some insight into Season 2 and what to expect.

Next Episode

Utilizing the Caregiver Trifecta (with Katie Brandt)

Every superhero has an origin story, and most caregivers can identify with the idea of coming from a place of challenge; “not one that they asked to be in, but one they must face.” In this episode our guest Katie Brandt shares with us her experiences as a care partner turned caregiver, and how that helps guide her professional and advocacy efforts for others who are faced with challenges from Alzheimer’s and other forms of dementia. She helps us untangle how to take the necessary steps toward caregiver self-care, and exactly who we need to lean on in order to consider all avenues of support by employing the “Caregiver Trifecta.” She shares stories of meaning, hope, and empowerment for anyone affected by these diseases.